Hsu CC - Search Results

1

Alcohol-associated liver disease predicts increased post-liver transplant opioid use.

Johnson-Laghi KA, Woo SM, Zafar Z, Fernandez S, Desale S, Robertazzi SE, Smith CI, Thomas AM, Lalos AT, Georgia SJ, Jenkins ML, Faust TW, Fishbein TM, Satoskar RS, Rangnekar AS, Hsu CC. Johnson-Laghi KA, et al. Among authors: hsu cc. Clin Transplant. 2022 Dec;36(12):e14811. doi: 10.1111/ctr.14811. Epub 2022 Sep 19. Clin Transplant. 2022. PMID: 36057863

2

Safety and efficacy of sofosbuvir/velpatasvir/voxilaprevir in post-liver transplant patients with previous direct-acting antiviral failure: Six case reports.

Higley C, Hsu CC, Smith C, Nadella S, Lalos AT. Higley C, et al. Among authors: hsu cc. World J Hepatol. 2020 Dec 27;12(12):1341-1348. doi: 10.4254/wjh.v12.i12.1341. World J Hepatol. 2020. PMID: 33442459 Free PMC article.

3

Risk factors for bleeding hepatocellular adenoma in a United States cohort.

McDermott C, Ertreo M, Jha R, Ko J, Fernandez S, Desale S, Fishbein T, Satoskar R, Winslow E, Smith C, Hsu CC. McDermott C, et al. Among authors: hsu cc. Liver Int. 2022 Jan;42(1):224-232. doi: 10.1111/liv.15087. Epub 2021 Nov 12. Liver Int. 2022. PMID: 34687281

4

Therapies for hepatocellular carcinoma: overview, clinical indications, and comparative outcome evaluation-part one: curative intention.

Yacoub JH, Hsu CC, Fishbein TM, Mauro D, Moon A, He AR, Bashir MR, Burke LMB. Yacoub JH, et al. Among authors: hsu cc. Abdom Radiol (NY). 2021 Aug;46(8):3528-3539. doi: 10.1007/s00261-021-03069-w. Epub 2021 Apr 9. Abdom Radiol (NY). 2021. PMID: 33835223 Review.

5

Therapies for hepatocellular carcinoma: overview, clinical indications, and comparative outcome evaluation. Part two: noncurative intention.

Yacoub JH, Mauro D, Moon A, He AR, Bashir MR, Hsu CC, Fishbein TM, Burke LMB. Yacoub JH, et al. Among authors: hsu cc. Abdom Radiol (NY). 2021 Aug;46(8):3540-3548. doi: 10.1007/s00261-021-03074-z. Epub 2021 Apr 16. Abdom Radiol (NY). 2021. PMID: 33864107 Review.

6

Safety and Pharmacokinetic Assessment of Oral Proglumide in Those with Hepatic Impairment.

Hsu CC, Bansal S, Cao H, Smith CI, He AR, Gay MD, Li Y, Cheema A, Smith JP. Hsu CC, et al. Pharmaceutics. 2022 Mar 12;14(3):627. doi: 10.3390/pharmaceutics14030627. Pharmaceutics. 2022. PMID: 35336003 Free PMC article.

7

A Gut Feeling: Acute Liver Failure - An Unusual Manifestation of Malignant Catatonia.

Kiparizoska S, Davis W, Duong M, Griffith N, Hsu C. Kiparizoska S, et al. Cureus. 2021 May 25;13(5):e15242. doi: 10.7759/cureus.15242. Cureus. 2021. PMID: 34188984 Free PMC article.

8

Iron overload disorders.

Hsu CC, Senussi NH, Fertrin KY, Kowdley KV. Hsu CC, et al. Hepatol Commun. 2022 Aug;6(8):1842-1854. doi: 10.1002/hep4.2012. Epub 2022 Jun 14. Hepatol Commun. 2022. PMID: 35699322 Free PMC article. Review.

9

Workup and Management of Immune-Mediated Hepatobiliary Pancreatic Toxicities That Develop During Immune Checkpoint Inhibitor Treatment.

Hsu C, Marshall JL, He AR. Hsu C, et al. Oncologist. 2020 Feb;25(2):105-111. doi: 10.1634/theoncologist.2018-0162. Epub 2019 Sep 9. Oncologist. 2020. PMID: 32043797 Free PMC article.

10

The Effects of Alcohol on Other Chronic Liver Diseases.

Hsu CC, Kowdley KV. Hsu CC, et al. Clin Liver Dis. 2016 Aug;20(3):581-94. doi: 10.1016/j.cld.2016.02.013. Epub 2016 Apr 5. Clin Liver Dis. 2016. PMID: 27373618 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,499 results

Search Page